News
In invasive lung carcinomas, including non-small cell lung cancer (NSCLC), the TMB ranges from 10 to nearly 1,000 mutations per million bases of exonic (i.e., protein-coding) DNA sequence; for ...
After chemotherapy there was no further evidence of disease. But, the five-year survival rate for stage 2 lung cancer, after treatment, is only 35%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results